You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Suppliers and packagers for NUTRILIPID 20%


✉ Email this page to a colleague

« Back to Dashboard


NUTRILIPID 20%

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun NUTRILIPID 20% soybean oil INJECTABLE;INJECTION 019531 NDA B. Braun Medical Inc. 0264-4460-00 8 CARTON in 1 CASE (0264-4460-00) / 1 CONTAINER in 1 CARTON / 1000 mL in 1 CONTAINER 2014-06-30
B Braun NUTRILIPID 20% soybean oil INJECTABLE;INJECTION 019531 NDA B. Braun Medical Inc. 0264-4460-10 12 CARTON in 1 CASE (0264-4460-10) / 1 CONTAINER in 1 CARTON / 500 mL in 1 CONTAINER 2014-06-30
B Braun NUTRILIPID 20% soybean oil INJECTABLE;INJECTION 019531 NDA B. Braun Medical Inc. 0264-4460-30 12 CARTON in 1 CASE (0264-4460-30) / 1 CONTAINER in 1 CARTON / 250 mL in 1 CONTAINER 2014-06-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: NutriLipID 20%

Last updated: August 8, 2025

Introduction

The pharmaceutical industry’s demand for specialty lipids like NutriLipID 20% underscores the critical role of high-quality lipid-based excipients and active ingredients in drug formulation. NutriLipID 20% is a lipid product primarily used in nutritional and pharmaceutical applications, often valued for its bioavailability and compatibility in parenteral nutrition, lipid emulsions, and drug delivery systems. Identifying reliable suppliers for NutriLipID 20% involves understanding market dynamics, key manufacturers, and distribution channels that ensure product quality, regulatory compliance, and supply continuity.

This report delineates the leading suppliers, evaluates market players, highlights procurement considerations, and provides strategic insights for pharmaceutical companies sourcing NutriLipID 20%.

Overview of NutriLipID 20%

NutriLipID 20% is a lipid emulsion composed mainly of long-chain triglycerides, delivering 20% lipid concentration. It serves as a nutritional supplement to deliver essential fatty acids and calories, and as a carrier in parenteral nutrition. Its stability, purity, and compliance with pharmacopeial standards like USP, EP, or Ph. Eur. are non-negotiable for pharmaceutical applications.

Key Manufacturers and Suppliers

1. Fresenius Kabi

Fresenius Kabi is a global leader in infusion therapies and lipid emulsions. Their lipid products, including NutriLipID equivalents, are widely supplied for clinical and pharmaceutical settings.

  • Product Portfolio: Lipid emulsions with varying concentrations (10%, 20%, 30%)
  • Market Presence: Global, with manufacturing facilities in Europe, North America, and Asia

Strengths: Proven quality, extensive distribution network, regulatory compliance, and robust R&D pipeline.

Contact: Fresenius Kabi official website

2. Baxter International Inc.

Baxter supplies lipid emulsions used in total parenteral nutrition (TPN). Their lipid products meet strict regulatory standards and are sourced worldwide.

  • Product Range: Lipid emulsions such as Lipiderm 20%
  • Global Reach: North America, Europe, Asia

Strengths: High regulatory standards, comprehensive quality assurance, and global logistics network.

3. Air Liquide Healthcare

Air Liquide supplies medical gases and lipid-based nutritional products, including specialist lipid emulsions for pharmaceutical applications.

  • Specialty: Custom lipid formulations, including 20% emulsions
  • Partnerships: Collaborations with pharmaceutical manufacturers

Strengths: Customization options, innovation in lipid technology, regulatory adherence.

4. GlaxoSmithKline (GSK)

GSK offers lipid emulsions primarily for clinical nutrition and investigational drugs, functioning as a supplier for pharmaceutical-grade lipids.

  • Lipid Products: Emulsions similar to NutriLipID with tailored specifications
  • Competitive Advantage: Established reputation, extensive R&D

5. Industrial Manufacturers and Custom Lipid Suppliers

Apart from major pharmaceutical corporations, several chemical and lipid manufacturing firms produce custom lipid emulsions:

  • CordenPharma: Specializes in lipid excipients and emulsions for parenteral nutrition.
  • Lipoid GmbH (a part of Clariant): Known for pharmaceutical excipients, including lipid solutions.
  • Croda International: Produces lipid-based ingredients catering to pharma and nutraceutical sectors.

These suppliers often offer tailored formulations compliant with regional regulatory standards.

Regulatory and Quality Standards

Suppliers of NutriLipID 20% must comply with pharmacopeial standards and regulatory approvals. Key considerations include:

  • Good Manufacturing Practices (GMP): Ensures consistency and safety.
  • BSE/TSE Free Certification: For parenteral applications.
  • Certificate of Analysis: Detailing purity, stability, and microbiological specifications.
  • Regulatory Approvals: US FDA, EMA, and other regional certifications.

Market Dynamics and Procurement Strategies

The global supply chain for pharmaceutical lipids is influenced by:

  • Regulatory Stringency: Leading suppliers maintain rigorous quality assurance to meet global standards.
  • Supply Chain Reliability: Manufacturers with diversified production sites minimize risk of shortages.
  • Customization and R&D: Suppliers offering tailored products gain competitive advantage.
  • Price Sensitivity: High-quality lipid emulsions command premium pricing; volume-based negotiations are common.

Procurement strategies should prioritize suppliers with proven regulatory compliance, scalable production, and reliable logistics.

Emerging Trends and Opportunities

  • Sustainable Manufacturing: Increasing focus on eco-friendly processes and biodegradable packaging.
  • Biotechnology Innovations: Development of bioengineered lipids for enhanced therapeutic performance.
  • Regional Diversification: Sourcing from emerging markets to mitigate geopolitical risks.

Conclusion

The primary suppliers of NutriLipID 20% are industry giants like Fresenius Kabi, Baxter, and specialized lipid manufacturers such as CordenPharma and Lipoid GmbH. Ensuring supplier qualification involves rigorous evaluation of quality systems, regulatory compliance, production capacity, and supply chain resilience. Pharmaceutical entities should leverage detailed supplier audits, establish long-term partnerships, and stay attuned to technological advancements in lipid emulsion manufacturing.


Key Takeaways

  • Leading suppliers include Fresenius Kabi, Baxter, Air Liquide Healthcare, and specialized lipid manufacturers like CordenPharma and Lipoid GmbH.
  • Regulatory compliance and quality assurance are non-negotiable when sourcing NutriLipID 20% for pharmaceutical applications.
  • Diversification of suppliers can mitigate risks associated with supply chain disruptions.
  • Customization options are available from certain manufacturers to meet specific formulation requirements.
  • Market trends favor sustainable production and biotechnology-led innovations, offering potential for future supplier partnerships.

FAQs

Q1: What are the primary considerations when selecting a supplier for NutriLipID 20%?
A: Quality standards (GMP compliance), regulatory approvals, reliability of supply, product consistency, and customization capacity.

Q2: Are there regional differences in suppliers for NutriLipID 20%?
A: Yes, regional regulations influence supplier availability; European and North American suppliers tend to have more rigorous approvals, but emerging markets are expanding offerings.

Q3: Can NutriLipID 20% be customized?
A: Many suppliers provide tailored lipid emulsions considering triglyceride composition, particle size, and excipients, subject to regulatory constraints.

Q4: What impact does supply chain disruption have on sourcing NutriLipID 20%?
A: Disruptions can lead to shortages; diversifying suppliers and maintaining safety stock mitigate these risks.

Q5: What future innovations could influence suppliers of NutriLipID 20%?
A: Bioengineered lipids, sustainable manufacturing methods, and formulations optimized for targeted drug delivery are key areas of innovation.


Sources

  1. Fresenius Kabi. Corporate Website. https://www.fresenius.com
  2. Baxter International Inc.. Corporate Website. https://www.baxter.com
  3. Lipoid GmbH. Pharmaceutical Lipid Products. https://www.lipoid.com
  4. CordenPharma. Custom Lipid Emulsions. https://www.cordenpharma.com
  5. Global Market Insights. Lipid Emulsions Market Report. 2022.

Note: For procurement-specific advice, consult with industry-specific sourcing consultants or directly engage with manufacturers.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.